ASIA Stock Overview
Does not have significant operations. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Asia Green Biotechnology Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0 |
| 52 Week High | CA$0.08 |
| 52 Week Low | CA$0.005 |
| Beta | 1.03 |
| 1 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | n/a |
Recent News & Updates
Shareholder Returns
| ASIA | CA Biotechs | CA Market | |
|---|---|---|---|
| 7D | n/a | -0.8% | -0.5% |
| 1Y | n/a | 3.6% | 15.6% |
Return vs Industry: Insufficient data to determine how ASIA performed against the Canadian Biotechs industry.
Return vs Market: Insufficient data to determine how ASIA performed against the Canadian Market.
Price Volatility
| ASIA volatility | |
|---|---|
| ASIA Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 13.9% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CA Market | 17.6% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ASIA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ASIA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2017 | n/a | David Pinkman | n/a |
Asia Green Biotechnology Corp. does not have significant operations. Previously, it was focused on the development, evaluation, testing, application, and supply of products derived from proprietary organic hybridization technology. The company was formerly known as Asia Cannabis Corp. and changed its name to Asia Green Biotechnology Corp. in April 2020.
Asia Green Biotechnology Corp. Fundamentals Summary
| ASIA fundamental statistics | |
|---|---|
| Market cap | CA$543.71k |
| Earnings (TTM) | -CA$250.48k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs ASIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ASIA income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$250.48k |
| Earnings | -CA$250.48k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0069 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -46.7% |
How did ASIA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/07/06 22:42 |
| End of Day Share Price | 2024/04/08 00:00 |
| Earnings | 2024/03/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Asia Green Biotechnology Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|